SpyGlass Pharma, Inc. Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current
SpyGlass Pharma, Inc. (SGP) had Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current of $0 as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Other Liabilities and Financial Instruments Subject to Mandatory Redemption
us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent · last filed 2026-03-26
- 2025-12-31: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current $0.00.
- 2024-12-31: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current $3.42M.
| Period end | Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 |
| 2024-12-31 | $3.42M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |